Day: September 13, 2023

ST. JOHN’S, Newfoundland and Labrador, Sept. 13, 2023 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) will hold its 2023 Investor Day on Tuesday, September 19, 2023 in St. John’s, Newfoundland and Labrador. David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer and executives from certain subsidiaries will provide an update on operations, recent developments and the strategic outlook for 2024 to 2028. The formal presentation is scheduled from 10:00 a.m. to 12:00 p.m. NDT (8:30 a.m. to 10:30 a.m. EDT). Shareholders, analysts, members of the media and other interested parties are invited to listen to the formal presentation via the live webcast on the Corporation’s website, https://www.fortisinc.com/investor-relations/events-and-presentations....

NEW YORK, Sept. 13, 2023 (GLOBE NEWSWIRE) — In response to the devastation caused by the catastrophic floods in Libya, Verizon is making it easier for customers in the United States to communicate with loved ones overseas who have been impacted by the disaster. Effective September 11 through September 24, Verizon will waive international long distance charges for calls and texts from its postpaid consumer and business wireless customers, as well as residential landline customers, to Libya. All calls will be rated at $0.00 per minute. In addition, Verizon will waive international roaming and data charges for customers traveling in Libya. For prepaid customers using Straight Talk, Tracfone, Total by Verizon, Simple Mobile, Safelink, Walmart Family Mobile, Verizon Prepaid, Net10, GoSmart, and Page Plus, Verizon will waive international...

MINNEAPOLIS, Sept. 13, 2023 (GLOBE NEWSWIRE) — Fresh Vine Wine Inc. (NYSE American: VINE) today announced that it received notice from NYSE American LLC (“NYSE American”) on September 8, 2023 that it is not in compliance with the continued listing standard set forth in Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”). That section applies if a listed company has stockholders’ equity of less than $4 million and has reported losses from continuing operations and/or net losses in three of its four most recent fiscal years. The Company reported stockholders’ equity of $2.4 million as of June 30, 2023, the end of its second fiscal quarter of 2023, and has had losses from continuing operations and/or net losses in each of its fiscal years ended December 31, 2020, 2021 and 2022. As a...

TULSA, OK, Sept. 13, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc., a Delaware corporation (NYSE: VTLE) (“Vital Energy” or the “Company”), announced today the commencement of an underwritten public offering of 2,500,000 shares of its common stock, subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase up to 375,000 additional shares of the Company’s common stock. The Company intends to use a portion of the net proceeds from this offering and a concurrent offering of senior notes to repay a portion of the borrowings outstanding under its senior secured credit facility and use any excess for general corporate purposes. Pending the use of the net proceeds from this offering as described in above, the Company intends to use the net proceeds from this offering to make short-term...

TULSA, OK, Sept. 13, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc., a Delaware corporation (NYSE: VTLE) (“Vital Energy” or the “Company”), announced today that it intends, subject to market conditions, to publicly offer $300 million in aggregate principal amount of 10.125% senior unsecured notes due 2028 and $500 million in aggregate principal amount of senior unsecured notes due 2030 in a registered underwritten offering for a total of $800 million. The Company intends to use a portion of the net proceeds from this offering of the notes and a concurrent offering of common stock to fund the satisfaction and discharge of the indenture governing its 9.500% senior unsecured notes due 2025, to repay a portion of the borrowings outstanding under its senior secured credit facility and use any excess for general corporate purposes. Wells...

Acquisitions and optimized development to increase 2024 Free Cash Flow¹ by approximately 90%², strengthen capital structure and add approximately 150 high-value locations TULSA, OK, Sept. 13, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital Energy” or the “Company”) today announced the signing of three definitive agreements that will materially add scale in the Permian Basin, increase Free Cash Flow, enhance capital efficiency and significantly reduce leverage. Combined, the transactions have a total consideration of approximately $1.1653 billion, subject to customary closing price adjustments. The agreements were signed with affiliates of Henry Energy LP and Henry Resources LLC (“Henry”), Tall City Property Holdings III LLC (“Tall City”) and Maple Energy Holdings,...

NORCROSS, Ga., Sept. 13, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11-13, 2022. The Wainwright Conference – which takes place at the Lotte New York Palace Hotel in New York City, New York – brings together thought leaders and practitioners from numerous fields to participate in presentations, one-on-one investor meetings, and networking opportunities with other attendees. Dr. Pol F. Boudes, Galectin Therapeutics’ Chief Medical Officer, will deliver a corporate presentation on Wednesday, September 13, 2023 at 12:00 PM ET. A live webcast of the discussion will be available at this link as well as through...

New cell biology data from Europe shows simufilam interrupts a pathogenic signaling pathway in Alzheimer’s disease. Results corroborate prior research from other academic researchers. These data once again confirm the biological activity of simufilam.AUSTIN, Texas, Sept. 13, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer’s disease, today announced the publication of new research that confirms the biological activity of simufilam. Simufilam is Cassava Sciences’ novel drug candidate for people with Alzheimer’s disease dementia and is currently under evaluation in a pair of global Phase 3 clinical trials. Researchers at the Cochin Institute (Paris, France) used a highly precise cell-based assay to show that simufilam interrupts amyloid binding to the α7 nicotinic acetylcholine...